Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Common stock, par value $0.0001 per share · CUSIP: 00032Q104

Event date: 2025-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • AVORO CAPITAL ADVISORS LLCReported CIK 0001633313

    Shares: 9,515,802.00 · Class: 18.0%

  • AVORO VENTURES LLCReported CIK 0001879253

    Shares: 2,288,950.00 · Class: 4.8%

  • BEHZAD AGHAZADEHReported CIK 0001701815

    Shares: 11,914,961.00 · Class: 19.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-001335
Form type
SCHEDULE 13D/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Mar 04, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub